Stephen Kilmer
Investor Relations
Replay available
BioRestorative Therapies, Inc. (NASDAQ: BRTX) Q1 2025 earnings conference call, held 2025-05-14. Replay captured from the company's public earnings webcast.

Investor Relations
Chairman and Chief Executive Officer
Chief Financial Officer
Vice President, Research and Development
Analyst, Roth Capital
Analyst, Maxim Group
Watch the replay and follow the connected company analysis, news, and investor updates for Biorestorative Therapies, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.499 Good afternoon, everyone, and welcome to the BioRestorative Therapies First Quarter 00:00:05.499 -- 00:00:07.302 2025 Investor 00:00:07.302 -- 00:00:12.309 Call. At this time, all participants are in a listen-only mode, 00:00:12.309 -- 00:00:16.475 and the floor will be open for questions following the presentation. 00:00:16.475 -- 00:00:21.423 If anyone should require operator assistance during the conference, please press star 00:00:21.423 -- 00:00:26.490 zero on your phone keypad. Please note this conference is being recorded. 00:00:26.490 -- 00:00:31.119 I will now turn the conference over to your host, Stephen Kilmer, Investor Relations. 00:00:31.119 -- 00:00:34.400 Stephen, the floor is yours. 00:00:34.822 -- 00:00:37.505 Thank you, Jenny. Good afternoon, everyone. 00:00:37.505 -- 00:00:42.129 Let me start by pointing out that this conference call will include four looking statements 00:00:42.129 -- 00:00:47.091 within the meaning of the Private Securities Litigation Reform Act of 1995. 00:00:47.313 -- 00:00:51.937 All four looking statements are based on biorestorative therapy's current beliefs, assumptions, 00:00:51.937 -- 00:00:56.421 and expectations. And such statements involve known and unknown risks, uncertainties, 00:00:56.421 -- 00:01:00.945 and other factors that that may cause actual results, performance, or achievements to 00:01:00.945 -- 00:01:04.268 be materially different from those implied by such statements. 00:01:04.268 -- 00:01:07.250 No forward-looking statement can be guaranteed. 00:01:07.250 -- 00:01:12.334 For details on factors, among others, that could affect expectations, see Part 1, Item 00:01:12.334 -- 00:01:17.419 1A of our annual report on Form 10-K for the year ended December 31, 2024, 00:01:17....